Results Hyperactivity Rating Scale pre: active: placebo" True" Hyperactives (n= 10): 50.80:
40.30: 47.40" Situational" Hyperactives:(n= 16): 46.66: 32.75: 42.62 3-way ANOVA (group x …

Objectives: To determine the effects of methylphenidate treatment on child growth in Thai
pediatric patients with attention-deficit/hyperactivity disorder (ADHD). Methods: The medical …

Aim To investigate parenting and mother–child interactions in unaffected siblings of autistic
children. Method This cross‐sectional study enrolled 274 probands with a DSM‐5 diagnosis …

Neurotrophin 3 (NTF3) has been studied in relation to the pathophysiology of attention-
deficit/hyperactivity disorder (ADHD) and mood disorders as well as psychostimulant action …

Given the shortage of studies on parental perceived benefits of OROS-methylphenidate
treatment in Asian populations, we assessed parental response to OROS-methylphenidate …

Objectives: To explore the clinical and health-related quality of life (HRQoL) outcomes in
children/adolescents with attention-deficit/hyperactivity disorder (ADHD) who required a …

Objectives: The aim of this study was to evaluate adherence to treatment by adolescents
with mental disorders who applied to the child and adolescent psychiatry outpatient clinic of …

Patients with ADHD may have better adherence to treatment with modified-release
methylphenidate (MPH-MR) formulations, which are taken once daily, compared with …

Background Osmotic release oral system methylphenidate (OROS-MPH) is one of the most
commonly used medication for attention-deficit hyperactivity disorder (ADHD), however, real …

目的对中国儿童青少年注意缺陷多动障碍(ADHD) 来说, 哌醋甲酯速释片(IR mPH),
哌醋甲酯控释片(OROS mPH) 和托莫西汀(AHc) 等3 种药物的疗效, 安全性等问题尚存在争议 …